Lumida
/SNYR
⌘K
SNYR

SNYR

SNYR
$0.19USD-4.56%-0.01 today

MARKET CAP

2.8M

P/E (TTM)

FWD P/E

0.5x

DAY RANGE

$0 – $0

52W RANGE

$0
$4

The case for & against

Bull & Bear analysis

Bearish

Synergy CHC Corp. (NASDAQ: SNYR) operates in the cannabis health and wellness space, focusing on dietary supplements and functional beverages. The company has been reformulating its product offerings, particularly its flagship Focus Factor brand, to better align with emerging health trends such as GLP-1 support. The firm aims for strategic growth, expanding its international footprint and enhancing its retail distribution, particularly in the North American market, demonstrating an intent to capture a larger share of the evolving consumer health landscape.

Bull says

  • Achieved 11th straight profitable quarter, proving operational resilience.
  • Reduced net debt by $6.5M, boosting cash to $2.6M for liquidity.
  • Signed retail partnerships (Costco) and expanded into Mexico markets.
  • Launched new Flat Tummy and RTD beverage lines with existing retailers.
  • Roth Capital reiterates Buy with $7 target on beverage rollout.
  • 1.75% dividend yield and high quality score suggest undervaluation.

Bear says

  • Q4 net revenue fell 41% YoY to $6.07M after licensing reversals.
  • Gross margin declined to 36.6% from 63.3%, driven by inventory write-offs.
  • Recorded $14.82M net loss, reflecting hefty one-time charges.
  • Operating expenses surged on public company compliance costs.
  • Cash burn of $14.82M in operations signals liquidity strain.
  • Flat Tummy weight-loss line pressured by rising GLP-1 competition.

Earnings Call · Q4 2024 · Mgmt. Guidance

Updated 07-16-2026neutral

Transcript signals

Bull points

  • We are pleased to report another fantastic year. We had another full year of profitability marking our eighth consecutive profitable quarter, a testament to the strength of our business model and dedication of our team.
  • I'm happy to report that this process is now behind us and we expect Synergy to return to both top line and bottom line growth in 2025.
  • We successfully completed our listing on the NASDAQ, raising over $6.2 million in net proceeds, and we finalized our rebranding of the Focus Factor brand, which we hadn't done since 2015.

Bear points

  • Our fourth quarter results would be impacted by the same retailer de-inventory situation related to the rebranding of our focus factor products. This initiative required retailers to clear out existing inventory before restocking and the updated packaging, which impacted short-term demand.
  • The information on this call contains forward-looking statements. These statements are often characterized by terminologies such as believe, hope, may, anticipate, expect, will, and other similar expressions.
  • As Jack discussed, the decline was driven by new packaging for our focus factor products that led to a de-inventorying dynamic at our retail partners, which caused them to pause their ordering while they sold through their existing inventory to reach acceptable reorder levels.
Read full transcript analysis ›